Skip to main content
European Commission logo
enen
Public Health

SCCNFP opinions 1997-2004

The opinions are published by the European Commission in their original language. Only this version is the original one. If other linguistic versions appear on this page, these will be clearly identified. The opinions are those of the Scientific Committees. It does not necessarily reflect the position of the European Commission.

  • Opinion concerning UVASORB K2A adopted on 1 July 2004 by means of the written procedure.
  • Opinion concerning Benzisothiazolinone Colipa n° P96 adopted on 1 July 2004 by means of the written procedure.
  • Opinion concerning Iodopropynyl Butylcarbamate Colipa n° P91 adopted on 1 July 2004 by means of the written procedure.
  • Opinion concerning Dibutylphtalate adopted on 1 July 2004 by means of the written procedure.
  • Opinion concerning Lead Acetate adopted on 1 July 2004 by means of the written procedure.
  • Opinion concerning Report for Establishing the Timetable for Phasing out Animal Testing for the purpose of the Cosmetics Directive issued by ECVAM (30/04/2004) adopted on 1 July 2004 by means of the written procedure.
  • Updated Position Paper concerning Consumer Safety of Alpha-Hydroxy Acids adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning Tetrabromophenol Blue Colipa n°:/ adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning 4-Methylbenzylidene Camphor Colipa n°S60 adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning Pigment Red 57 Colipa n°:/ adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning Musk Xylene and Musk Ketone adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning Furfural adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning Chemical Ingredients in Cosmetic Products classified as Carcinogenic, Mutagenic or Toxic to reproduction according to the Chemicals Directive 67/548/EEC adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning Acid Blue 62 Colipa n°C67 adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning Acid Yellow 3 Colipa n°C54 adopted during the 28th plenary meeting of 25 May 2004.
  • Opinion concerning Acetaldehyde adopted during the 28th plenary meeting of 25 May 2004.
  • Recommended Mutagenicity/Genotoxicity tests for the safety testing of cosmetic ingredients to be included in the annexes to Council Directive 76/768/EEC (SCCNFP Notes of Guidance) adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning use of permanent hair dyes and bladder cancer updated 2004 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Ring study on reaction products from typical combinations of hair colouring ingredients adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Methylisothiazolinone Colipa n° P94 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Methyldibromo Glutaronitrile Colipa n° P77 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning HC Blue 15 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Hair Dyes without File submitted adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Acid Red 52 Colipa n° C177 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Acid Red 18 Colipa n° C175 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Curry Red Colipa n° C174 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Indigofera Tinctoria Colipa n° C170 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Acid Red 92 Colipa n° C53 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Acid Blue 9 Colipa n° C40 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Adic Yellow 23 Colipa n° C29 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Acid Orange 7 Colipa n° C15 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Basic Violet 2 Colipa n° B115 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning N,N'-Bis-(2-Hydroxyethyl)-2-Nitro-P-Phenylenediamine Colipa n° B34 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Acid Yellow 1 Colipa n° B1 adopted on 23 April 2004 by means of the written procedure.
  • Opinion concerning Lawsone Colipa n° C146 adopted on 16 February 2004 by means of the written procedure.
  • Proposal for recommended mutagenicity / genotoxicity tests for the safety testing of cosmetic ingredients to be included in the annexes to council Directive 76/768/EEC (SCCNFP's notes of guidance) adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning an update of the initial list of perfumery materials which must not form part of cosmetic products except subject to the restrictions and conditions laid dow adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning an update of the initial list of perfumery materials which must not form part of fragrance compounds used in cosmetic products.adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning Benzethonium Chloride Colipa n° P70 adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning Hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral®) adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning Linalool adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning Isopimpinellin adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning Diethyl phthalate adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning Choline Chloride adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning 6-Hydroxyindole Colipa n° a128 adopted during the 26th plenary meeting of 9 December 2003.
  • Opinion concerning furocoumarins in sun protection and bronzing products adopted during the 26th plenary meeting of 9 December 2003.
  • The SCCNFP'S notes of guidance for the testing of cosmetic ingredients and their safety evaluation (5th Revision) adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexylester adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning HC Blue N° 14 Colipa n° C172 adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning Bergamottin adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning Basic Yellow 87 adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning Basic Red 51 adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning Basic Orange 31 adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning PEG-3,2',2'-di-p-phenylenediamine Colipa n° A146 adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning 2,6-dihydroxyethylaminotoluene Colipa n° A138 adopted during the 25th plenary meeting of 20 october 2003.
  • Opinion concerning 2-chloro-6-methyl-3-aminophenol hydrochloride Colipa n° A 94 adopted during the 25th plenary meeting of 20 october 2003
  • Opinion concerning 2,4,5,6-tetraaminopyrimidine Colipa n° A 53 adopted during the 25th plenary meeting of 20 october 2003 .
  • Opinion concerning basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients (updated october 2003) adopted during the 25th plenary meeting of 20 october 2003 .
  • Consultation concerning risks and health effects from tattoos, body piercing and related practices adopted during the 25th plenary meeting Of 20 october 2003.
  • Opinion concerning use of specified risk material in cosmetics clarification for tallow derivatives adopted on 30 July 2003 by means of the written procedure.
  • Opinion concerning Zinc Pyrithione Colipa n° P81, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Updated Recommended Strategy for Testing Hair Dyes for their Potential Genotoxicity/Mutagenicity/Carcinogenicity, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Benzoic Acid, 2-[4-(Diethylamino)-2-Hydroxybenzoyl]-, Hexylester, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Zinc Oxide Colipa n° S 76, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Update of entry n° 39 of Annex VI to Directive 76/768/EEC on Cosmetic Products : Mixture of 5-Chloro-2-Methyl-Isothiazolin-3(2H)-One and 2- Methylisothiazolin-3(2H)-One Colipa n° P56, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Methyl Acetate, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning the Safety of Fluorine Compounds in Oral Hygiene Products for Children under the Age of 6 Years, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Essential Oils, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Basic Yellow 57 Colipa n° C10, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning HC Yellow n° 7 Colipa n° B80, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning HC Yellow n° 9 Colipa n° B69, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning HC Orange n° 3 Colipa n° B68, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning HC Yellow n° 11 Colipa n° B63, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning 2-Nitro-5-Glyceryl Methylaniline Colipa n° B60, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning 6-Nitro-O-Toluidine Colipa n° B56, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Disperse Red 17 Colipa n° B5, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning HC Red nº 7 Colipa n° B36, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning HC Yellow n° 13 Colipa n° B102, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning Azole Antimycotic Resistance, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning 2,5,6-Triamino-4-Pyrimidinol Sulfate Colipa n° a143, adopted during the 24th plenary meeting of 24-25 June 2003
  • Opinion concerning wood tars and wood tar preparations, adopted during the 23rd plenary meeting of of 18 march 2003
  • Opinion concerning request for a re-evaluation of hair dyes listed in annex iii to directive 76/768/eec on cosmetic products, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning methylisothiazolinone colipa n° p94, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning inorganic sulfites and bisulfites colipa n° p51, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning ethoxyethanol, ethoxyethanol acetate, 2-methoxyethanol and 2-methoxyethanol acetate (glycol ethers and their acetates), adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning basic brown 16 colipa n° c9, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning basic red 76 colipa n° c8, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning hc green nº 1 colipa n° c129, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning hc red nº 8 colipa n° c119, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning 4-amino-2-nitrodiphenylamine-2'-carboxylic acid colipa n° b87, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning dihydroxyindoline hbr colipa n° : a147, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning hc blue n° 7 colipa n° a130, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning 5-amino-4-chloro-o-cresol hcl colipa n° a117, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning dihydroxyindole colipa n°: a111, adopted during the 23rd plenary meeting of 18 march 2003
  • Opinion concerning 2,4-dichlorobenzyl alcohol (DCBA) colipa n° p74, adopted on 10 January 2003 by means of the written procedure
  • Opinion concerning the determination of certain formaldehyde releasers in cosmetic products, adopted during the 22nd plenary meeting of 17 december 2002
  • Opinion concerning a clarification on the formaldehyde and para-formaldehyde entry in Directive 76/768/EEC on cosmetic products , adopted during the 22nd plenary meeting of 17 december 2002
  • Opinion concerning amendment to entry n° 419 of annex II to Directive 76/768/EEC on cosmetic products, adopted during the 22nd plenary meeting of 17 december 2002
  • Updated basic requirements for toxicological dossiers to be evaluated by the SCCNFP revision 17 december 2002, adopted during the 22nd plenary meeting of 17 december 2002
  • Assessment strategies for hair dyes, adopted during the 22nd plenary meeting of 17 December 2002
  • Opinion on AHTN, adopted during the 21st plenary meeting of 17 September 2002
  • Opinion on Lawsone (C146), adopted during the 21st plenary meeting of 17 September 2002
  • Opinion on Henna (C169), adopted during the 21st plenary meeting of 17 September 2002
  • Opinion on HHCB, adopted during the 21st plenary meeting of 17 September 2002
  • Opinion on Hydrogen peroxide tooth bleaching/whitening products, adopted during the 21st plenary meeting of 17 September 2002
  • Opinion on Ketoconazole, adopted during the 21st plenary meeting of 17 September 2002
  • Opinion on Triclosan (P32), adopted during the 21st plenary meeting of 17 September 2002
  • Opinion on Consultation on Methods to replace Animal Testing, adopted on 29 July 2002 by means of the written procedure
  • Memorandum concerning the actual status of alternative methods to the use of animals in the safety testing of cosmetic ingredients adopted by the SCCNFP during the 20th plenary meeting of 04 June 2002
  • Proposal for a strategy for testing hair dye cosmetic ingredients for their potential genotoxicity/mutagenicity adopted by the SCCNFP during the 20th plenary meeting of 04 June 2002
  • Position statement concerning fragrance chemicals in detergents and other household products adopted by the SCCNFP during the 20th plenary meeting of 04 June 2002
  • Opinion on Salicylic Acid adopted by the SCCNFP during the 20th plenary meeting of 04 June 2002
  • Opinion on Methyldibromo Glutaronitrile (colipa n° p77) adopted by the SCCNFP during the 20th plenary meeting of 04 June 2002
  • Opinion on Diethyl Phthalate adopted by the SCCNFP during the 20th plenary meeting of 04 June 2002 Corrigendum - Section 2.11, calculation of MoS (page 29/30): please note that the values for potential exposure of 6 mg/d (ethanol denaturant) and 0.02 mg/d (fragrance solvent) have been replaced by 5.6 mg/d and 28 mg/d, respectively. MoS values of 150 (worst case calculation), 1500 (ethanol denaturant) and 15000 (fragrance solvent) have been replaced by the MoS values of 161, 1607 and 321, respectively. This correction does not change the conclusion of the opinion.
  • Opinion on the use of Benzoyl Peroxide (BPO) Hydroquinone (HQ), Hydroquinone Methylether (MEHQ) in artificial nail systems adopted by the SCCNFP during the 20th plenary meeting of 04 June 2002
  • Opinion on Benzoic Acid and Sodium Benzoate adopted by the SCCNFP during the 20th plenary meeting of 04 June 2002
  • Position statement on consumer safety of detergents, household & similar products adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning Piroctone olamine and its monoethanolamine salt ( Colipa n° P59) adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning Hexamidine and its salts, including di-isethionate and di(p-hydroxybenzoate) ( Colipa n° P8) adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning Disperse Violet 1 impurified with Disperse Red 15 ( Colipa n° C64 & C61) adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning Lawsone (Colipa n° C146) adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning Benzethonium chloride (Colipa n° P70) adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning Tetrahydro-6-nitroquinoxaline (Colipa n° B104) adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning p-Phenylenediamine (Colipa n° A7) adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning the safety review of the use of certain azo-dyes in cosmetic products adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Opinion concerning amendment to entry n° 419 of annex II to Directive 76/768/EEC on cosmetic products adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002
  • Discussion paper on assessment strategies for hair dyes adopted by the SCCNFP during the 19th plenary meeting of 27 February 2002 The Commission services invite interested parties for their comments. Please send your comments before 6 May 2002 at the following e-mail address : Antoon [dot] van-elstatec [dot] europa [dot] eu
  • Position statement on the calculation of the margin of safety of ingredients incorporated in cosmetics which may be applied to the skin of children adopted by the SCCNFP during the 19th Plenary meeting of 27 February 2002
  • Opinion concerning amendment to entry n° 419 of annex II to Directive 76/768/EEC on cosmetic products adopted by the SCCNFP during the 18 th Plenary meeting of 25 September 2001
  • Opinion concerning an initial list of perfumery materials which must not form part of cosmetic products except subject to the restrictions and conditions laid down adopted by the SCCNFP during the 18 th Plenary meeting of 25 September 2001
  • Opinion concerning chemical ingredients in cosmetic products classified as carcinogenic, mutagenic or toxic to reproduction according to the chemicals Directive 67/548/EEC adopted by the SCCNFP during the 18 th Plenary meeting of 25 September 2001
  • Opinion concerning the Use of Alpha-Tocopherol Acetate in Cosmetic Products adopted by the SCCNFP during the 18 th Plenary meeting of 25 September 2001
  • Memorandum on Scientific Evaluations and Opinions adopted by the SCCNFP during the 17th Plenary Meeting of 12 June 2001
  • Opinion concerning Amendment to entry N° 419 of Annex II to Directive 76/768/EEC on cosmetic products adopted by the SCCNFP during the 17th Plenary Meeting of 12 June 2001
  • Opinion on the use of Permanent Hair Dyes and Bladder Cancer Risk adopted by the SCCNFP during the 17th Plenary Meeting of 12 June 2001
  • Opinion concerning Dialkyl- and Dialkanolamines and their salts in cosmetic products adopted by the SCCNFP during the 17th plenary meeting of 12 June 2001
  • Opinion on the Evaluation of Potentially Estrogenic Effects of UV-filters adopted by the SCCNFP during the 17th Plenary meeting of 12 June 2001
  • Position Statement concerning para-Phenylenediamine and similar Substances and their use in Skin Stains (Temporary Tattoos) adopted by the SCCNFP during the 16th Plenary Meeting of 13 March 2001
  • Opinion concerning Lawsone Colipa n° C146 adopted by the SCCNFP during the 16 th plenary meeting of 13 March 2001
  • Opinion concerning 1-Naphtol Colipa n° A17 adopted by the SCCNFP during its 16th plenary meeting of 13 March 2001
  • Memorandum on the Opinion concerning Fragrance Allergy in Consumers adopted by the SCCNFP during the 16th Plenary Meeting of 13 March 2001
  • Opinion concerning Titanium Dioxide, Colipa n° S75 adopted by the SCCNFP during the 14th plenary meeting of 24 October 2000
  • Opinion concerning 6-Acetyl-1,1,2,4,4,7-hexamethyltetraline (AHTN) adopted by the SCCNFP during the 14th plenary meeting of 24 October 2000
  • Opinion concerning the 1st update of the inventory of ingredients employed in cosmetic products section II : perfume and aromatic raw materials (adopted by the SCCNFP during the plenary session of 24 October 2000)
  • Notes of guidance for testing of cosmetic ingredients for their safety evaluation (Adopted by the SCCNFP during the plenary meeting of 24 October 2000)
  • Opinion concerning the revision of Annex 7 of the notes of guidance on Guidelines for the safety assessment of the finished cosmetic product adopted by the SCCNFP during the plenary meeting of 24 October 2000
  • Opinion concerning Methyleugenol adopted by the SCCNFP during the 14th plenary meeting of 24 October 2000
  • Opinion concerning Hexahydro-hexamethyl-cyclopenta (g )-2-benzopyran (HHCB) adopted by the SCCNFP during the 14th plenary meeting of 24 October 2000
  • Opinion concerning Oakmoss/Treemoss Extracts And Appropriate Consumer Information adopted by the SCCNFP during the 14th plenary meeting of 24 October 2000
  • Opinion on the 1st update of the inventory of ingredients employed in cosmetic products (section1) adopted by the SCCNFP during the 13th plenary session of 28 June 2000 + Annex
  • Opinion concerning Amino Acids Obtained By Hydrolysis Of Human Hair adopted by the SCCNFP during its 13th plenary meeting of 28 June 2000
  • Position Paper concerning the Safety of alpha-Hydroxy Acids. The Commission services invite interested parties for their comments. Please send your comments before 15 September 2000 at the following e-mail address : antoon.van-elst AT ec.europa.eu
  • Opinion concerning Hydroxypropyl bis (N-hydroxyethyl-p phenylenediamine), HCl Colipa A121 adopted by the SCCNFP during the 13th plenary meeting of 28 June 2000
  • Opinion concerning Refined Coal Tar by Bi-distillation adopted by the SCCNFP during the 13th Plenary meeting of 28 June 2000
  • Opinion concerning Basic Blue 7 Colipa n° C46 adopted by the SCCNFP during the 12 th plenary meeting of 3 May 2000
  • Opinion concerning Lithium Hydroxide and Calcium Hydroxide, Modification to entries n° 15b and 15c in Annex III to Directive 76/768/EEC on Cosmetic Products adopted by the SCCNFP during the 12 th Plenary meeting of 3 May 2000
  • Opinion concerning an initial list of perfumery materials which must not form part of fragrances compounds used in cosmetic products ( adopted by the SCCNFP during the 12 th Plenary meeting of 3 May 2000)
  • Opinion concerning Diaminopyrimidine oxide (2,4-DPO) adopted by the SCCNFP during the 12 th plenary meeting of 3 May 2000
  • Opinion on the Murine Local Lymph Node Assay (LLNA) adopted by the SCCNFP during the 12 th plenary meeting of 3 May 2000
  • Position paper on the Phenomenon of Quenching adopted by the SCCNFP during the 11th Plenary meeting of 17 February 2000
  • Opinion concerning Basic requirements for toxicological dossiers to be evaluated by the SCCNFP adopted by the SCCNFP during the 11th plenary meeting of 17 February 2000
  • The Classification of Substances adopted by the SCCNFP during the 11th Plenary meeting of 17 February 2000
  • Opinion concerning the Safety of Tattoos adopted by the SCCNFP during the 11th Plenary meeting of 17 February 2000
  • Opinion concerning m-Aminophenol Colipa n° A15 adopted by the SCCNFP during the 11th plenary meeting of 17 February 2000
  • Opinion concerning 2-Amino-3-nitrophenol Colipa n° B55 adopted by the SCCNFP during the 11th plenary meeting of 17 February 2000
  • Opinion concerning 4-Amino-3-nitrophenol Colipa n° B51 adopted by the SCCNFP during the 11th plenary meeting of 17 February 2000
  • Opinion concerning 2,6 Dihydroxy-3,4-dimethylpyridine Colipa n° A99 adopted by the SCCNFP during the 11th plenary meeting of 17 February 2000
  • Opinion concerning 2,7-Naphthalenediol Colipa n° A19 adopted by the SCCNFP during the 11th plenary meeting of 17 February 2000
  • Opinion concerning the predictive testing of potentially cutaneous sensiting cosmetic ingredients or mixtures of ingredients adopted by the SCCNFP during the 11th plenary session of 17 February 2000
  • Opinion concerning basic criteria of the protocols for the skin compatibility testing of potentially cutaneous irritant cosmetic ingredients or mixtures of ingredients on human volunteers - Adopted by the SCCNFP during the plenary session of 8 December 1999
  • Opinion concerning Musk Ketone adopted by the plenary session of the SCCNFP of 8 December 1999
  • The Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers concerning Fragrance Allergy in Consumers
  • Opinion of The Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers concerning Musk Xylene
  • Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers concerning 3-Iodo-2-propynyl-butylcarbamate (IPBC) - Colipa n° P 91 adopted by the plenary session of the SCCNFP of 23 June 1999
  • Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers concerning ACRYLAMIDE RESIDUES IN COSMETICS adopted by the plenary session of the SCCNFP of 30 September 1999
  • Draft pre-opinion of the Scientific Committee on Cosmetic Products and non-food products intended for consumers concerning Fragrance allergy in consumers (30 Septembre 1999)
  • Opinion concerning 2,4-Diamino-5-methylphenetol HCL (Colipa n° A113) - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary session of 23 June 1999
  • Opinion concerning 2,6-Dimethoxy-3,5-Pyridinediamine HCL (Colipa n° A101) - adopted by the Scientific Committee for Cosmetic Products and Non-food products intended for Consumers during the plenary session of 23 June 1999
  • Opinion concerning 1,7-Naphthalenediol (Colipa n° A1) - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary session of 23 June 1999
  • Clarification of the Opinion concerning Hydrogen (carbamide) peroxide in Tooth Whitening Products - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary session of 23 June 1999
  • Opinion concerning the interim position on fragrance allergy - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary session of 23 June 1999
  • Opinion concerning guidelines on the use of human volunteers in compatibility testing of finished cosmetic products - adopted during the plenary session of 23 June 1999
  • Opinion concerning basic criteria for the in vitro assessment of percutaneous absorption of cosmetic ingredients - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary session of 23 June 1999
  • Opinion concerning Strontium Lactate, Nitrate and Polycarboxylate - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning present development and validation of adequate alternative methodologies to the use of animals in safety testing of cosmetics - adopted during the plenary of 23 June 1999
  • Opinion concerning hydrogen peroxide and hydrogen peroxide releasing substances used in oral care products - adopted during the plenary session of 23 June 1999
  • Opinion concerning Ketoconazole adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning HC violet n° 2 (Colipa n° B98) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning 6-Nitro-2,5-pyridinediamine (Colipa n° B92) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning Hydroxyethyl-2,6-dinitro-p-anisidine (Colipa n° B90) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning HC Bleu n° 11 (Colipa n° B77) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning Hydroxyethyl-2-nitro-p-toluidine (Colipa n° B75) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning HC Blue n° 12 (Colipa n° B73) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning 2-Hydroxyethylpicramic acid (Colipa n° B72) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning 4-Hydroxypropylamino-3-nitrophenol (Colipa n° B100) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary session of 23 June 1999
  • Opinion concerning 1,3-Bis-(2,4-diaminophenoxy)propane (Colipa n° A79) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning 3-Amino-2,4-dichlorophenol (Colipa n° A43) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning Phenylmethylpyrazolon (Colipa n° A39) - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning 2-Methyl-5-hydroxyethylaminophenol (Colipa n° A31) - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning Hydroxybenzomorpholine (Colipa n° A25) - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning p-Methylaminophenol (Colipa n° A22) - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning 1-Naphthol (Colipa n° A17) - adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning 2,4-Diamino-5-methylphenoxyethanol HCL (Colipa n° A116) - adopted by the Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers during the plenary of 23 June 1999
  • Opinion concerning banning of Dialkanolamines which are still in the inventory adopted by the plenary session of the SCCNFP on 17 February 1999
  • Opinion of concerning 1,4-Dihydroxybenzene - Colipa n°A21 - adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion of concerning Benzylhemiformal - Colipa n° P 21 - adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion of concerning Hydrogen (Carbamide) Peroxide in Tooth Whitening Products adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion concerning Corrections in entries of poloxamers, meroxapols and poloxamines, and respective nomenclature conventions adopted by the plenary session of the SCCNFP on 17 February 1999
  • Opinion concerning Restrictions on materials listed in Annex VI of Directive 76/768/EEC on cosmetic products adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion concerning 4-Isopropylbenzyl salicylate - Colipa n° S16 - adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion concerning 2-Hydroxy-4-methoxybenzophenone-5-sulphonic acid - Colipa n° S40 - adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion concerning Benzylidene malonate polysiloxane - Colipa n° S74 - adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion concerning 2,2'-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-
    (1,1,3,3-tetramethylbutyl)phenol) - Colipa n° S79 - adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion concerning 2-Ethylhexyl-4-dimethylaminobenzoate - Colipa n° S8 - adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion concerning 2,2'-(1,4-Phenylene)bis)-1H-benzimidazole-4,6-
    disulfonic acid, monosodium salt) - Colipa n° S80 adopted by the plenary session of the SCCNFP of 17 February 1999
  • Opinion concerning 2,4-bis-{[4-(2-Ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-
    (4-methoxyphenyl)-(1,3,5)-triazine - Colipa n° S81 adopted by the plenary session of the SCCNFP of 17 February 1999
  • Status report on the inventory on cosmetic ingredients approved by the plenary session of the SCCNFP on 17 February 1999
  • Opinion on the use of alternative methods to animal testing in the safety evaluation of cosmetic ingredients or mixtures of ingredients (with three annexes) and the updating of notes of guidance for testing of cosmetic ingredients for their safety evaluation (with two annexes) adopted by the SCCNFP at the plenary meeting of 20 January 1999
  • Opinion on in vitro methods to assess percutaneous absorption of cosmetic ingredients adopted by the plenary session of the SCCNFP of 20 January 1999
  • Opinion on in vitro methods to assess skin corrosivity in the safety evaluation of cosmetic ingredients or mixtures of ingredients adopted by the plenary session of the SCCNFP of 25 November 1998
  • Opinion on in vitro methods to assess phototoxicity in the safety evaluation of cosmetic ingredients or mixtures of ingredients adopted by the plenary session of the SCCNFP of 25 November 1998
  • Opinion - Guidelines on the use of human volunteers in the testing of potentially cutaneous irritant cosmetic ingredients or mixtures of ingredients adopted by the plenary session of the SCCNFP of 25 November 1998
  • Opinion concerning Strontium Lactate, Nitrate and Polycarboxylate adopted by the plenary session of the SCCNFP of 23 September 1998
  • Opinion concerning Foreseeable Use of Hair Dyes adopted by the plenary session of the SCCNFP of 23 September 1998
  • Opinion concerning Boric Acid, Borates and Tetraborates adopted by the plenary session of the SCCNFP of 23 September 1998
  • Opinion concerning 1,5-dihydroxynaphthalene adopted by the plenary session of the SCCNFP 20 May 1998
  • Opinion concerning 4-N,N-bis(ß-hydroxyethyl)-2-nitro-p-phenylenediamine adopted by the plenary session of the SCCNFP 20 May 1998
  • Opinion concerning 1-amino-2-nitro-4-(ß-hydroxyethyl)amino-5-chloro-benzene adopted by the plenary session of the SCCNFP 20 May 1998
  • Opinion concerning 2-hydroxyethylamino-5-nitroanisole adopted by the plenary session of the SCCNFP 20 May 1998
  • Opinion concerning 1-(2-hydroxyethyloxy)-3-methylamino-4-nitrobenzene adopted by the plenary session of the SCCNFP 20 May 1998
  • Opinion concerning 1,5-di-(ß-hydroxyethylamino)-2-nitro-4-chloro-benzene adopted by the plenary session of the SCCNFP 20 May 1998
  • Opinion concerning 1-amino-3-methyl-4-(2-hydroxyethyl)-amino-6-nitrobenzene adopted by the plenary session of the SCCNFP 20 May 1998
  • Opinion concerning C.I. 42 640 adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning Benzoic acid, 4,4-{[6-[[[(1,1-dimethyl)amino]carbonyl]phenyl] amino]-1,3,5-triazine-2,4-diyl)diimino}bis-, bis(2-ethylhexyl)ester adopted by the plenary session of January 21, 1998
  • Opinion concerning 3-benzylidenebornan-2-one adopted by the plenary session of 21 January 1998
  • Opinion concerning 3-(4'-methylbenzylidene)-d,l camphor adopted by the plenary session of January 21, 1998
  • Opinion concerning 2-ethylhexyl salicylate adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning Zirconium and compounds adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning Tyrothricin and salts adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning 3,4',5-Tribromosalicylanilide adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning Tetrahydrozoline and Salts adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning 2,3,7,8-Tetrachlorodibenzo-P-Dioxin adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning Strontium lactate, Strontium nitrate and Strontium Polycarboxylate adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning Phytolacca species and preparations adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning Minoxidil and salts adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion intended for Consumers concerning Aristolochic acid and salts adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion intended for Consumers concerning Antiandrogens with steroid structure adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion intended for Consumers concerning 7-Acetyl-6-Ethyl-1,1,4,4-Tetramethyl-1,2,3,4-Tetrahydronaphtalen (AETT) adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning Acetonitrile adopted by the plenary session of the SCCNFP of 21 January 1998
  • Opinion concerning 11-Alpha-Hydroxypregn-4-Ene 3,20-Dione adopted by the plenary session of the SCCNFP of 21 January 1998
  • Notes of Guidance for Testing of Cosmetic Ingredients for their Safety Evaluation (Third Revision, Adopted: 23 June 1999) (updated version)
  • Statement on the toxicological evaluation
  • Classification of Substances as ingredients of cosmetic products
  • Opinion concerning 4,6-dinitro-1,1,3,3,5-Pentamethylindane adopted by the plenary session of the SCC of 24 June 1997
  • Opinion concerning 5-tert-butyl-1,2,3-trimethyl-4,6-Dinitrobenzene adopted by the plenary session of the SCC of 24 June 1997
  • Opinion concerning Isopentyl-p-Methoxycinnamate adopted by the plenary session of the SCC of 24 June 1997
  • Opinion concerning Ethoxylated Ethyl-4-Aminobenzoate adopted by the plenary session of the SCC of 14 October 1997
  • Opinion concerning 2,4,6-Trianilino-(p-carbo-2‘-ethylhexyl-1‘-oxi)-1,3,5-triazine adopted by the plenary session of the SCC of 24 June 1997
  • Opinion concerning Phenol,2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3- tetramethyl-1-(trimethylsilyl)oxy)-disiloxanyl)propyl) adopted by the plenary session of the SCC of 24 June 1997
  • Opinion concerning Strontium chloride hexahydrate adopted by the plenary session of the SCC of 24 June 1997